148 related articles for article (PubMed ID: 16275646)
1. RNA polymerase II blockage by cisplatin-damaged DNA. Stability and polyubiquitylation of stalled polymerase.
Jung Y; Lippard SJ
J Biol Chem; 2006 Jan; 281(3):1361-70. PubMed ID: 16275646
[TBL] [Abstract][Full Text] [Related]
2. Transcription-coupled and DNA damage-dependent ubiquitination of RNA polymerase II in vitro.
Lee KB; Wang D; Lippard SJ; Sharp PA
Proc Natl Acad Sci U S A; 2002 Apr; 99(7):4239-44. PubMed ID: 11904382
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of RNA polymerase II transcription in human cell extracts by cisplatin DNA damage.
Cullinane C; Mazur SJ; Essigmann JM; Phillips DR; Bohr VA
Biochemistry; 1999 May; 38(19):6204-12. PubMed ID: 10320349
[TBL] [Abstract][Full Text] [Related]
4. Dynamic Behavior of the RNA Polymerase II and the Ubiquitin Proteasome System During the Neuronal DNA Damage Response to Ionizing Radiation.
Casafont I; Palanca A; Lafarga V; Mata-Garrido J; Berciano MT; Lafarga M
Mol Neurobiol; 2016 Dec; 53(10):6799-6808. PubMed ID: 26660115
[TBL] [Abstract][Full Text] [Related]
5. RNA polymerase II stalled on a DNA template during transcription elongation is ubiquitinated and the ubiquitination facilitates displacement of the elongation complex.
Yang LY; Jiang H; Rangel KM
Int J Oncol; 2003 Mar; 22(3):683-9. PubMed ID: 12579324
[TBL] [Abstract][Full Text] [Related]
6. Multiple states of stalled T7 RNA polymerase at DNA lesions generated by platinum anticancer agents.
Jung Y; Lippard SJ
J Biol Chem; 2003 Dec; 278(52):52084-92. PubMed ID: 14534300
[TBL] [Abstract][Full Text] [Related]
7. Behavior of T7 RNA polymerase and mammalian RNA polymerase II at site-specific cisplatin adducts in the template DNA.
Tornaletti S; Patrick SM; Turchi JJ; Hanawalt PC
J Biol Chem; 2003 Sep; 278(37):35791-7. PubMed ID: 12829693
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of transcriptional stalling at cisplatin-damaged DNA.
Damsma GE; Alt A; Brueckner F; Carell T; Cramer P
Nat Struct Mol Biol; 2007 Dec; 14(12):1127-33. PubMed ID: 17994106
[TBL] [Abstract][Full Text] [Related]
9. Fate of RNA polymerase II stalled at a cisplatin lesion.
Tremeau-Bravard A; Riedl T; Egly JM; Dahmus ME
J Biol Chem; 2004 Feb; 279(9):7751-9. PubMed ID: 14672951
[TBL] [Abstract][Full Text] [Related]
10. DNA damage-dependent transcriptional arrest and termination of RNA polymerase II elongation complexes in DNA template containing HIV-1 promoter.
Wang Z; Rana TM
Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6688-93. PubMed ID: 9192626
[TBL] [Abstract][Full Text] [Related]
11. Influence of irofulven, a transcription-coupled repair-specific antitumor agent, on RNA polymerase activity, stability and dynamics in living mammalian cells.
Escargueil AE; Poindessous V; Soares DG; Sarasin A; Cook PR; Larsen AK
J Cell Sci; 2008 Apr; 121(Pt 8):1275-83. PubMed ID: 18388315
[TBL] [Abstract][Full Text] [Related]
12. Blockage of RNA polymerase II at a cyclobutane pyrimidine dimer and 6-4 photoproduct.
Mei Kwei JS; Kuraoka I; Horibata K; Ubukata M; Kobatake E; Iwai S; Handa H; Tanaka K
Biochem Biophys Res Commun; 2004 Aug; 320(4):1133-8. PubMed ID: 15249207
[TBL] [Abstract][Full Text] [Related]
13. DNA adducts of cis-diamminedichloroplatinum(II) and its trans isomer inhibit RNA polymerase II differentially in vivo.
Mello JA; Lippard SJ; Essigmann JM
Biochemistry; 1995 Nov; 34(45):14783-91. PubMed ID: 7578087
[TBL] [Abstract][Full Text] [Related]
14. Effect of a monofunctional phenanthriplatin-DNA adduct on RNA polymerase II transcriptional fidelity and translesion synthesis.
Kellinger MW; Park GY; Chong J; Lippard SJ; Wang D
J Am Chem Soc; 2013 Sep; 135(35):13054-61. PubMed ID: 23927577
[TBL] [Abstract][Full Text] [Related]
15. Conformation and recognition of DNA damaged by antitumor cis-dichlorido platinum(II) complex of CDK inhibitor bohemine.
Novakova O; Liskova B; Vystrcilova J; Suchankova T; Vrana O; Starha P; Travnicek Z; Brabec V
Eur J Med Chem; 2014 May; 78():54-64. PubMed ID: 24675180
[TBL] [Abstract][Full Text] [Related]
16. Transcription-dependent polyubiquitination of RNA polymerase II requires lysine 63 of ubiquitin.
Lee KB; Sharp PA
Biochemistry; 2004 Dec; 43(48):15223-9. PubMed ID: 15568815
[TBL] [Abstract][Full Text] [Related]
17. Rescue of DNA damage-stalled RNA Pol II: histone H2B in action.
Mao P; Smerdon MJ
RNA Dis; 2014; 1(1):. PubMed ID: 25705722
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin-induced ubiquitination of RNA polymerase II large subunit and suppression of induction by 7-hydroxystaurosporine (UCN-01).
Yang LY; Jiang H; Rangel KM; Plunkett W
Oncol Rep; 2003; 10(5):1489-95. PubMed ID: 12883729
[TBL] [Abstract][Full Text] [Related]
19. Single-stranded breaks in DNA but not oxidative DNA base damages block transcriptional elongation by RNA polymerase II in HeLa cell nuclear extracts.
Kathe SD; Shen GP; Wallace SS
J Biol Chem; 2004 Apr; 279(18):18511-20. PubMed ID: 14978042
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Cellular RNA polymerase II transcription by delta antigen of hepatitis delta virus.
Lo K; Sheu GT; Lai MM
Virology; 1998 Aug; 247(2):178-88. PubMed ID: 9705911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
